Cargando…
Cerebral Dopamine Neurotrophic Factor Diffuses Around the Brainstem and Does Not Undergo Anterograde Transport After Injection to the Substantia Nigra
Cerebral dopamine neurotrophic factor (CDNF) has shown therapeutic potential in rodent and non-human primate models of Parkinson’s disease by protecting the dopamine neurons from degeneration and even restoring their phenotype and function. Previously, neurorestorative efficacy of CDNF in the 6-hydr...
Autores principales: | Albert, Katrina, Renko, Juho-Matti, Mätlik, Kert, Airavaara, Mikko, Voutilainen, Merja H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580362/ https://www.ncbi.nlm.nih.gov/pubmed/31244598 http://dx.doi.org/10.3389/fnins.2019.00590 |
Ejemplares similares
-
AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models
por: Albert, Katrina, et al.
Publicado: (2017) -
Intrastriatally Infused Exogenous CDNF Is Endocytosed and Retrogradely Transported to Substantia Nigra
por: Mätlik, Kert, et al.
Publicado: (2017) -
Implementation of deep neural networks to count dopamine neurons in substantia nigra
por: Penttinen, Anna‐Maija, et al.
Publicado: (2018) -
Isolated substantia nigra involvement in brainstem demyelination
por: Mahale, Rohan R., et al.
Publicado: (2015) -
Neuroprotective and reparative effects of endoplasmic reticulum luminal proteins – mesencephalic astrocyte-derived neurotrophic factor and cerebral dopamine neurotrophic factor
por: Albert, Katrina, et al.
Publicado: (2019)